Transthyretin-IN-2 (Compound 36) is a transthyretin (TTR) amyloidsis inhibitor, with IC50 and pIC50 values of 1.31 μM and 5.88 μM. Transthyretin-IN-2 can be used for the research of TTR amyloidosis diseases[1].

Transthyretin-IN-3 (compound 6) is a designed benzofuran analogue. Transthyretin-IN-3 selectively binds to plasma transthyretin(TTR) to inhibit Amyloid aggregation(IC50 = 5.0 ± 0.2 μM). Transthyretin-IN-3 can bind to TTR’s thyroxine binding site specifically by carrying chlorine substituents at specific locations in its structure. This binding can prevent TTR tetramers from dissociating into unstable monomers[1].

TRAP1 Human Pre-designed siRNA Set A contains three designed siRNAs for TRAP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRAPPC1 Human Pre-designed siRNA Set A contains three designed siRNAs for TRAPPC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRAPPC11 Human Pre-designed siRNA Set A contains three designed siRNAs for TRAPPC11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRAPPC12 Human Pre-designed siRNA Set A contains three designed siRNAs for TRAPPC12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRAPPC2 Human Pre-designed siRNA Set A contains three designed siRNAs for TRAPPC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRAPPC2L Human Pre-designed siRNA Set A contains three designed siRNAs for TRAPPC2L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRAPPC3 Human Pre-designed siRNA Set A contains three designed siRNAs for TRAPPC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRAPPC4 Human Pre-designed siRNA Set A contains three designed siRNAs for TRAPPC4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRAPPC5 Human Pre-designed siRNA Set A contains three designed siRNAs for TRAPPC5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRAPPC6A Human Pre-designed siRNA Set A contains three designed siRNAs for TRAPPC6A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRAPPC8 Human Pre-designed siRNA Set A contains three designed siRNAs for TRAPPC8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRAPPC9 Human Pre-designed siRNA Set A contains three designed siRNAs for TRAPPC9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRAT1 Human Pre-designed siRNA Set A contains three designed siRNAs for TRAT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRB Human Pre-designed siRNA Set A contains three designed siRNAs for TRB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRD Human Pre-designed siRNA Set A contains three designed siRNAs for TRD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRDMT1 Human Pre-designed siRNA Set A contains three designed siRNAs for TRDMT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRDN Human Pre-designed siRNA Set A contains three designed siRNAs for TRDN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TREH Human Pre-designed siRNA Set A contains three designed siRNAs for TREH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Trehalose C12 (α-D-Glucopyranosyl-α-D-glucopyranoside monododecanoate) is a nonreducing disaccharide with amphiphilic property, which is used as emulsifier, surfactant, encapsulating materials, and in the biochemical researches of cellular processes and membrane interactions[1].

Trehalose C14 is a surfactant[1].

TREM1 Human Pre-designed siRNA Set A contains three designed siRNAs for TREM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TREM2 Human Pre-designed siRNA Set A contains three designed siRNAs for TREM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TREML1 Human Pre-designed siRNA Set A contains three designed siRNAs for TREML1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TREML2 Human Pre-designed siRNA Set A contains three designed siRNAs for TREML2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TREML4 Human Pre-designed siRNA Set A contains three designed siRNAs for TREML4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Treprostinil-d7 (UT-15-d7) is a deuterated version of Treprostinil (HY-100441). Treprostinil is a highly potent DP1 and EP2 agonist with EC50s of 0.6 nM and 6.2 nM, respectively[1][2][3][4][5][6][7].

TRERF1 Human Pre-designed siRNA Set A contains three designed siRNAs for TRERF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TREX1 Human Pre-designed siRNA Set A contains three designed siRNAs for TREX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TREX1-IN-1 (Compound 180) is a TREX1 inhibitor with an IC50 value for hTREX1 less than 0.1 μM[1].

TREX2 Human Pre-designed siRNA Set A contains three designed siRNAs for TREX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRG Human Pre-designed siRNA Set A contains three designed siRNAs for TRG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRH Human Pre-designed siRNA Set A contains three designed siRNAs for TRH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRHDE Human Pre-designed siRNA Set A contains three designed siRNAs for TRHDE gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

TRHR Human Pre-designed siRNA Set A contains three designed siRNAs for TRHR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Tri-O-tolyl phosphate (Tri-O-cresyl phosphate; TOTP) is a biochemical reagent that can be used as a biological material or organic compound for life science related research[1].

TRIAP1 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIAP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Triapine (hydrochloride) is the hydrochloride form of Triapine (HY-10082). Triapine (3-AP; PAN-811) is a potent inhibitor of the M2 subunit of ribonucleotide reductase (RR), and is a potent radiosensitizer[1].

TRIB1 Human Pre-designed siRNA Set A contains three designed siRNAs for TRIB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.